Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction
- 14 July 2015
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 52 (6) , 301-313
Abstract
(2015). Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction. Critical Reviews in Clinical Laboratory Sciences: Vol. 52, No. 6, pp. 301-313. doi: 10.3109/10408363.2015.1041582Keywords
This publication has 117 references indexed in Scilit:
- Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitroDiabetologia, 2012
- The Size of Large Adipose Cells Is a Predictor of Insulin Resistance in First‐Degree Relatives of Type 2 Diabetic PatientsObesity, 2012
- Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast CancerCancer Prevention Research, 2011
- Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesitySurgery for Obesity and Related Diseases, 2011
- Regional differences in cellular mechanisms of adipose tissue gain with overfeedingProceedings of the National Academy of Sciences, 2010
- Single-cell analysis of insulin-regulated fatty acid uptake in adipocytesAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Distribution of Subcutaneous Fat Predicts Insulin Action in Obesity in Sex‐specific MannerObesity, 2008
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Decreased Expression of Adipogenic Genes in Obese Subjects with Type 2 DiabetesObesity, 2006
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004